Diseases, Conditions, Syndromes

COVID-19: Discovery spurs clinical trial of antidepressant

An antidepressant medication is being tested as a potential treatment for COVID-19 after University of Virginia School of Medicine researchers determined it may prevent dangerous overreactions by the immune system.

Medications

Common psychiatric drugs appear to reduce effect of COVID-19

A new meta-analysis shows that psychiatric medications can give some protection against COVID-19, with the common antidepressant fluvoxamine showing the strongest effect. Patients taking fluvoxamine showed reduced symptoms, ...

Medications

Fluvoxamine may prevent serious illness in COVID-19 patients

In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine ...

Medications

WHO advises against use of two drugs for non-severe COVID-19

The antidepressant drug fluvoxamine and the gout drug colchicine are not recommended for patients with mild or moderate COVID-19 because there is currently insufficient evidence that they improve important outcomes for patients, ...

page 1 from 2